Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile

MLA

Kara A. Scheibner, et al. “Personalized Synthetic Lethality Induced by Targeting RAD52 in Leukemias Identified by Gene Mutation and Expression Profile.” Blood, vol. 122, Aug. 2013, pp. 1293–304. EBSCOhost, https://doi.org/10.1182/blood-2013-05-501072.

APA

Kara A. Scheibner, Jae-Woong Lee, Kimberly Cramer-Morales, Margaret Nieborowska-Skorska, Mariusz A. Wasik, Mhairi Copland, Tomasz Skorski, Michelle Padget, Curt I. Civin, David Irvine, Huimin Geng, Kimberly Haas, Markus Müschen, Feyruz V. Rassool, Wayne E. Childers, Tomasz Sliwinski, Darshan Roy, & Artur Slupianek. (2013). Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile. Blood, 122, 1293–1304. https://doi.org/10.1182/blood-2013-05-501072

Chicago

Kara A. Scheibner, Jae-Woong Lee, Kimberly Cramer-Morales, Margaret Nieborowska-Skorska, Mariusz A. Wasik, Mhairi Copland, Tomasz Skorski, et al. 2013. “Personalized Synthetic Lethality Induced by Targeting RAD52 in Leukemias Identified by Gene Mutation and Expression Profile.” Blood 122 (August): 1293–1304. doi:10.1182/blood-2013-05-501072.